Nouryant Europese Unie - Nederlands - EMA (European Medicines Agency)

nouryant

kyowa kirin holdings b.v. - istradefylline - ziekte van parkinson - geneesmiddelen tegen parkinson - istradefylline is indicated in adults as an adjunctive treatment to levodopa based regimens in patients with parkinson’s disease (pd) experiencing “off” time.